Soldotna, Alaska-based KAHTNU Surgical, Inc. has raised $2.15 million in Series A funding as well as announced a key strategic partnership.
KAHTNU Surgical Lands $2.15 Million in Funding and Partnership

The Series A round of financing was led by Kinetic Medical Co., Ltd. KAHTNU Surgical plans to use the funding to expand worldwide sales and marketing efforts. It will also use the investment to increase its spine and orthopedic product development.
KAHTNU Surgical’s lead products include the KASILOF Cervical Plate, CHENA-C PEEK Spacer and TALKEETNA Pedicle Screw systems for spine surgery.
KAHTNU Surgical President and Chief Executive Officer Craig Wilcox discussed the funding saying, “This funding will accelerate the company’s ability to establish quality sales channels in the U.S. and aggressively expand our product development capabilities.”
Wilcox continued, “KAHTNU Surgical is committed to product development that harnesses existing and emerging technologies to improve outcomes for spine and orthopedic surgeons and their patients.”
In line with its sales expansion, KAHTNU Surgical also announced a partnership with Ortho Consulting Group Ltd (OCG). Based in the United Kingdom, OCG will use its expertise to develop KAHTNU Surgical’s sales channels outside the United States.
OCG Commercial Director Andrew Dubowski commented on the partnership saying, “We are thrilled to partner with KAHTNU Surgical.”
Dubowski continued, “The commitment they show to provide high quality/cost effective products in the spine industry makes this an exciting addition to our client portfolio. We are looking forward to helping KAHTNU Surgical grow globally.”
KAHTNU Surgical designs and manufactures products, programs, and services for orthopedic and spine surgeons. In July 2020 it changed its name from Axis360 Surgical. Wilcox commented on the name change saying, “This rebranding strategy more closely reflects the company’s origins as an Alaska company and the spirit of independence that is deeply ingrained in the Alaskan culture.”
Wilcox continued, “The word ‘Kahtnu’ is the native Athabascan’s name for the Kenai River, which runs through the beautiful Kenai Peninsula where our company was formed.”

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.